NX Prenatal

iPrenom

This molecular diagnostics company develops blood tests to detect and predict pregnancy complications for expectant mothers and healthcare providers.

NX Pharmagen

This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

Nexosome Oncology

The company develops exosome-based blood tests for early-stage cancer detection and provides biomarker discovery services for pharmaceutical and biotechnology organisations.

Aggamin

This biotechnology company develops an extracorporeal device to treat preeclampsia by reducing circulating pathogenic proteins for pregnant women and healthcare providers.

Singular Bio

The company develops single molecule detection technology for cell-free DNA analysis to provide non-invasive prenatal screening for the healthcare and genomics sectors.

Genomic Prediction

The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.

Bloomlife

This company develops wearable medical devices and a remote monitoring platform to help healthcare providers manage high-risk pregnancies and improve maternal health outcomes.